US stocks rise on earnings outlook, global shares dip on China data

By Herbert Lash NEW YORK (Reuters) -U.S. stocks rose on Monday on expectations corporate earnings will exceed forecasts, but global shares and the dollar traded little changed after data showed the Chinese economy grew slower than anticipated. China overnight reported growth of 0.8% in the second quarter, above the 0.5% forecast, but the annual pace…

Read More

Marriott enters licensing deal with MGM to boost presence in Las Vegas strip

By Doyinsola Oladipo (Reuters) -Marriott International said on Monday it entered a 20-year licensing agreement that will allow its loyalty members to earn and redeem existing points for booking stays at MGM Resorts International’s properties. Marriott and MGM are teaming up to offer benefits to loyalty members as travel companies use unique programs to keep…

Read More

End of Black Sea grains deal promises pain for Africa’s neediest

By Abdi Sheikh and Aaron Ross MOGADISHU (Reuters) – Russia’s announcement that it was withdrawing from a pact that allowed Ukrainian grains to leave Black Sea ports sent a shiver through poorer countries, many of which are already reeling from inflation, climate shocks and conflict. The Black Sea grains deal, brokered by the United Nations…

Read More

China slams planned US visit of ‘separatist’ Taiwan presidential front-runner

By Liz Lee and Ben Blanchard BEIJING/TAIPEI (Reuters) -China reacted with anger on Monday to a planned visit next month to the United States by “separatist” Taiwan presidential frontrunner Vice President William Lai, as the government in Taipei said it saw no reason to overreact to mere transit stops. Taiwanese presidents and vice presidents traditionally…

Read More

ProMIS Neurosciences Stock Surges on Unprecedented Growth Catalysts

ProMIS Neurosciences Inc. (NASDAQ: PMN) witnessed a significant surge in its share value on Monday, following a compelling presentation of preclinical data at AAIC 2023. The data showcased the promising therapeutic potential of their leading candidate, PMN310, for Alzheimer’s disease (AD), along with groundbreaking research on a computationally-derived AD vaccine. The findings revealed that PMN310…

Read More

US securities regulator ‘disappointed’ with defeat over Ripple’s XRP

WASHINGTON (Reuters) -The head of the U.S. securities regulator said Monday the agency was “disappointed” with a judge’s recent ruling that Ripple Labs Inc did not violate federal securities laws in a major blow to its efforts to rein in the cryptocurrency sector. U.S. Securities and Exchange Commission Chair Gary Gensler said his agency was…

Read More